What ingredients are in Mounjaro, and why do they matter?

The active ingredient: what tirzepatide actually is

Tirzepatide is a 39-amino-acid synthetic peptide, a lab-engineered sequence that mimics two naturally occurring gut hormones: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). Most people researching what the main ingredient in Mounjaro is stop at the name without understanding why two receptors matter. Activating GIP receptors and GLP-1 receptors at the same time produces a broader effect on appetite, gastric emptying and blood-glucose regulation than single-pathway medicines can achieve.

GLP-1 receptor agonists were already established in weight management before Mounjaro arrived. If you want to understand what tirzepatides are and why the GIP pathway changes the picture, evidence from the SURMOUNT-1 trial, published in the New England Journal of Medicine, showed average body-weight reductions of around 20–21% at the 15 mg dose over 72 weeks, results that place it among the most studied and clinically meaningful pharmacological options available in the UK. The full profile of tirzepatide covers the mechanism in more depth if you want to go further.

Tirzepatide is the active ingredient regardless of which Mounjaro strength your prescriber selects. The concentration rises as you move through the titration schedule; the molecule itself does not change.

The inactive ingredients: what else is in the pen

Every Mounjaro KwikPen contains a small set of excipients whose job is to keep tirzepatide stable in solution and to make the injection tolerable. The full list (verified on the Mounjaro Summary of Product Characteristics on the eMC) includes sodium phosphate dibasic heptahydrate, sodium phosphate monobasic monohydrate (together these act as a buffer to maintain pH), mannitol (a common stabiliser), polysorbate 80 (a surfactant that prevents aggregation of the peptide), and water for injections as the solvent.

None of these excipients are unusual. Polysorbate 80 and mannitol appear in many injectable medicines. Their presence is worth noting mainly for people with known hypersensitivities, which is one reason a prescriber reviews your medical history before approving treatment. If you have a documented allergy to any of these components, that conversation needs to happen first. The Patient Information Leaflet inside every pack lists the complete excipient set; read it before your first injection.

The formulation contains no animal-derived gelatin, no gluten, and no lactose. People with those dietary considerations sometimes ask about this specifically, and it's a reasonable question, the excipient list gives a clear answer.

What the ingredient profile means for how you might feel

Understanding what is in Mounjaro helps explain the most commonly reported side effects. The GI effects (nausea, loose stools, constipation, reflux, burping) arise primarily from the way tirzepatide slows gastric emptying and acts on gut receptors, not from the excipients. They tend to be most noticeable in the first week or two after starting or increasing a dose, then settle for most people.

Because tirzepatide slows gastric emptying, it can also affect how quickly oral medicines and oral contraceptives are absorbed, particularly early in treatment. The NHS advises women using the contraceptive pill to add a non-oral method of contraception for the first four weeks of Mounjaro use and for four weeks after any dose increase. Our page on electrolytes during Mounjaro treatment explores how the GI side-effect profile can affect hydration and what to consider alongside your regular routine.

A less-discussed point: the MHRA's January 2026 Drug Safety Update identified acute pancreatitis as an infrequent but serious known risk with GLP-1 medicines, including tirzepatide. Severe, persistent stomach pain that extends toward the back (with or without vomiting) warrants urgent medical attention. Report any suspected side effects via the MHRA Yellow Card scheme; this post-market surveillance is part of how the Black Triangle designation works in practice.

Does knowing the ingredients change whether Mounjaro is right for you?

For most people researching what ingredients are in Mounjaro, the practical question underneath is: will this suit me? The ingredient list itself rarely answers that. What matters clinically is your BMI, your weight-related health conditions, your current medicines, and your history. Mounjaro is licensed for adults with a BMI of 30 or above, or 27 and above where at least one weight-related condition is present, but the prescriber assesses the full picture, not just a number.

If you're weighing up Mounjaro against other options, the Mounjaro overview page sets out the clinical context, and a broader look at licensed weight-loss treatments covers how it sits alongside other medicines. For a clear view of what private treatment costs and what's included in a single transparent price, the Mounjaro pricing page is the place to start, it's worth reading before your consultation so you know exactly what you're comparing.

A note for anyone planning around a bank holiday or a busy stretch at work: our team reviews consultations the same working day, and orders placed before midday Monday to Friday are dispatched the same day once clinically approved, so timing your start doesn't need to be complicated. When you're ready, check your eligibility with our prescribers.